The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Serum anti-mullerian hormone and estradiol levels as predictors of ovarian hyperstimulation syndrome in assisted reproduction technology cycles
Abstract
BACKGROUND: Anti-Müllerian hormone (AMH) is reported to be a reliable marker of the ovarian response to controlled ovarian stimulation (COS). The objective of this study is to determine whether the serum AMH level can predict ovarian hyperstimulation syndrome (OHSS) prior to selection of COS protocols. METHODS: A cohort of 262 IVF cycles was investigated prospectively, in order to evaluate the predictive value for OHSS by means of certain risk factors, including age, body mass index (BMI), serum estradiol (E2) level, number of retrieved oocytes and basal serum AMH level. RESULTS: The basal serum AMH level predicted OHSS better than age and BMI with a sensitivity of 90.5% and specificity of 81.3%. Both the basal serum AMH level (odds ratio: 1.7856, P = 0.0003) and serum E2 level on the day of HCG administration (odds ratio: 1.0005, P = 0.0455) proved to be significant predictors of OHSS by logistic regression analysis. However, age (odds ratio: 0.9346, P = 0.049) was the only significant factor for prediction of clinical pregnancy. CONCLUSIONS: The basal serum AMH level could be utilized effectively to predict OHSS and thus to direct the selection of mild COS protocols.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Serum anti-Mullerian hormone levels: a novel measure of ovarian reserve
van Rooij, I. A. J. (2002) · Human Reproduction · doi:10.1093/humrep/17.12.3065 · Cited by 951
Ovarian Hyperstimulation Syndrome: An Update Review
GOLAN, A., RON-EL, R., HERMAN, A., & SOFFER, Y. (1989) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-198906000-00004 · Cited by 806
Regulation of ovarian function: the role of anti-Mullerian hormone
Durlinger, A. L., Visser, J. A., & Themmen, A. P. (2002) · Reproduction · doi:10.1530/rep.0.1240601 · Cited by 779
Anti-Mullerian Hormone Attenuates the Effects of FSH on Follicle Development in the Mouse Ovary
Durlinger, A. L. L., Gruijters, M. J. G., Kramer, P., Karels, B., Kumar, T. R., Matzuk, M. M., Rose, U. M., de Jong, F. H., Uilenbroek, J. T. J., Grootegoed, J. A., et al. (2001) · Endocrinology · doi:10.1210/en.142.11.4891 · Cited by 772
Fanchin, R. (2003) · Human Reproduction · doi:10.1093/humrep/deg042 · Cited by 624
Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment
Wallach, E. E., Navot, D., Bergh, P. A., & Laufer, N. (1992) · Fertility and Sterility · doi:10.1016/s0015-0282(16)55188-7 · Cited by 621
van Rooij, I. A. J., Broekmans, F. J. M., Scheffer, G. J., Looman, C. W. N., Habbema, J. D. F., de Jong, F. H., Fauser, B. J. C. M., Themmen, A. P. N., & te Velde, E. R. (2005) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.11.029 · Cited by 582
Serum anti-Mullerian hormone throughout the human menstrual cycle
La Marca, A., Stabile, G., Artenisio, A. C., & Volpe, A. (2006) · Human Reproduction · doi:10.1093/humrep/del291 · Cited by 532
Hehenkamp, W. J. K., Looman, C. W. N., Themmen, A. P. N., de Jong, F. H., te Velde, E. R., & Broekmans, F. J. M. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0331 · Cited by 509
Seifer, D. B., MacLaughlin, D. T., Christian, B. P., Feng, B., & Shelden, R. M. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(01)03201-0 · Cited by 494
Ovarian hyperstimulation syndrome
Budev, M. M., Arroliga, A. C., & Falcone, T. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000182795.31757.ce · Cited by 354
Papanikolaou, E. G., Pozzobon, C., Kolibianakis, E. M., Camus, M., Tournaye, H., Fatemi, H. M., Van Steirteghem, A., & Devroey, P. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2005.07.1292 · Cited by 336
La Marca, A., Giulini, S., Tirelli, A., Bertucci, E., Marsella, T., Xella, S., & Volpe, A. (2007) · Human Reproduction · doi:10.1093/humrep/del421 · Cited by 327
Cook, C. L., Siow, Y., Brenner, A. G., & Fallat, M. E. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(01)02944-2 · Cited by 266
Early follicular antimüllerian hormone as an indicator of ovarian reserve
Fiçicioǧlu, C., Kutlu, T., Baglam, E., & Bakacak, Z. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2005.09.019 · Cited by 248
Anti-Müllerian hormone and its role in ovarian function
Gruijters, M. J. G., Visser, J. A., Durlinger, A. L. L., & Themmen, A. P. N. (2003) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2003.09.024 · Cited by 238
Serum müllerian-inhibiting substance levels during normal menstrual cycles
Cook, C. L., Siow, Y., Taylor, S., & Fallat, M. E. (2000) · Fertility and Sterility · doi:10.1016/s0015-0282(99)00639-1 · Cited by 237
Serum anti-Mullerian hormone dynamics during controlled ovarian hyperstimulation
Fanchin, R. (2003) · Human Reproduction · doi:10.1093/humrep/deg043 · Cited by 227
Peñarrubia, J., Fábregues, F., Manau, D., Creus, M., Casals, G., Casamitjana, R., Carmona, F., Vanrell, J. A., & Balasch, J. (2005) · Human Reproduction · doi:10.1093/humrep/deh718 · Cited by 199
La Marca, A., Malmusi, S., Giulini, S., Tamaro, L. F., Orvieto, R., Levratti, P., & Volpe, A. (2004) · Human Reproduction · doi:10.1093/humrep/deh508 · Cited by 191
Chuang, C.-C., Chen, C.-D., Chao, K.-H., Chen, S.-U., Ho, H.-N., & Yang, Y. U.-S. (2003) · Fertility and Sterility · doi:10.1016/s0015-0282(02)04562-4 · Cited by 159
Self-citationEarly and late ovarian hyperstimulation syndrome: early pregnancy outcome and profile
Papanikolaou, E. G. E., Tournaye, H. J., Verpoest, W., Camus, M., Vernaeve, V., Steirteghem, A. V., & Devroey, P. (2004) · Human Reproduction · doi:10.1093/humrep/deh638 · Cited by 153
Mullerian Inhibitory Substance Induces Growth of Rat Preantral Ovarian Follicles1
McGee, E. A., Smith, R., Spears, N., Nachtigal, M. W., Ingraham, H. A., & Hsueh, A. J. W. (2001) · Biology of Reproduction · doi:10.1095/biolreprod64.1.293 · Cited by 125
Balasch, J. C. (1993) · Fertility and Sterility · doi:10.1016/s0015-0282(16)56005-1 · Cited by 123
Aboulghar, M. A. (2003) · Human Reproduction · doi:10.1093/humrep/deg208 · Cited by 103
Morris, R. S., Paulson, R. J., Sauer, M. V., & Lobo, R. (1995) · Human Reproduction · doi:10.1093/oxfordjournals.humrep.a136044 · Cited by 77
Chen, C. (2000) · Human Reproduction · doi:10.1093/humrep/15.5.1037 · Cited by 71
Lee, T., Wu, M., Chen, H., Chen, M., Ho, H., & Yang, Y. (2005) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.12.037 · Cited by 40
Self-citation
Cited by
Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART)
La Marca, A., Sighinolfi, G., Radi, D., Argento, C., Baraldi, E., Artenisio, A. C., Stabile, G., & Volpe, A. (2010) · Human Reproduction Update · doi:10.1093/humupd/dmp036 · Cited by 956
La Marca, A., & Sunkara, S. K. (2014) · Human Reproduction Update · doi:10.1093/humupd/dmt037 · Cited by 586
Broer, S. L., Dolleman, M., Opmeer, B. C., Fauser, B. C., Mol, B. W., & Broekmans, F. J. M. (2011) · Human Reproduction Update · doi:10.1093/humupd/dmq034 · Cited by 485
Prevention and treatment of moderate and severe ovarian hyperstimulation syndrome: a guideline
Pfeifer, S., Butts, S., Dumesic, D., Fossum, G., Gracia, C., La Barbera, A., Mersereau, J., Odem, R., Paulson, R., Penzias, A., et al. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.08.048 · Cited by 396
Anti-Mullerian hormone-based approach to controlled ovarian stimulation for assisted conception
Nelson, S. M., Yates, R. W., Lyall, H., Jamieson, M., Traynor, I., Gaudoin, M., Mitchell, P., Ambrose, P., & Fleming, R. (2008) · Human Reproduction · doi:10.1093/humrep/den480 · Cited by 339
Metadata
- Authors
- Lee, T.-H., Liu, C.-H., Huang, C.-C., Wu, Y.-L., Shih, Y.-T., Ho, H.-N., Yang, Y.-S., & Lee, M.-S.
- Venue
- Human Reproduction
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-11-16
- Volume
- 23
- Issue
- 1
- Pages
- 160-167
- ISSN
- 0268-1161 (ISSN-L)
- 1460-2350
- OpenAlex
- W2042670258
- Cited by
- 279
- References
- 28
- FWCI
- 12.01
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.